Electron Beam Computed Tomography in the Age of 64 Slice CT Matthew J. Budoff, MD, FACC Associate Professor of Medicine Division of Cardiology Harbor-UCLA.

Slides:



Advertisements
Similar presentations
Summary Prepared by Melvyn Rubenfire, MD
Advertisements

Potential Benefits and Limits
Lipid Management in 2015: Risk & Controversies
B. C. Kansupada, MD, HeartCare Assoc. ACC chapter talk 4/28/06.
CARDIAC CT BASIC PRINCIPLES AND CT CAG
Morteza Naghavi, M.D. Society for Heart Attack Prevention and Eradication (SHAPE) Detection and Treatment of Asymptomatic Atherosclerosis for Primary Prevention.
The Efficacy of Non-invasive Diagnostic for CAD in PMK Hospital Maj. Hutsaya Prasitdumrong, M.D. Cardiovascular Division, Department of Internal Medicine,
1. 2 The primary Objective of IDEAL LDL-C Simvastatin mg/d Atorvastatin 80 mg/d risk CHD In stable CHD patients IDEAL: The Incremental Decrease.
New concepts and guidelines in the management of LDL-c and CV Risk: Need for early intervention Prof. Ulf Landmesser University Hospital Zürich Switzerland.
Clinical Trials. Date & location – January-November 1998, stress SPECT patients randomly received tetrofosmin or sestamibi (n~1550) Inclusion criteria.
The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) The LIPID Study Group N Engl J Med 1998;339:
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
Presenter Disclosure Information Diane Bild, MD, MPH Screening for Subclinical Atherosclerosis as a Strategy for CVD Prevention FINANCIAL DISCLOSURE: None.
Coronary Artery Calcification & Computed Tomography Scoring.
Long-term predictive value of assessment of coronary atherosclerosis by contrast- enhanced coronary computed tomography angiography: meta- analysis and.
Morteza Naghavi, M.D. Founder Society for Heart Attack Prevention and Eradication (SHAPE) SHAPE Guidelines Prevention of Fatal Cardiovascular Events (Heart.
Coronary Calcium Scoring for Risk Stratification and Guidelines Matthew Budoff, MD, FACC, FAHA Professor of Medicine Director, Cardiac CT Harbor-UCLA Medical.
Surrogate Measures of Atherosclerosis and Implications for Evaluating Cardiovascular Risk Nathan D. Wong, Ph.D., F.A.C.C. Associate Professor and Director.
Screening and Treatment of Coronary Artery Disease Matthew J. Budoff, MD, FACC Associate Professor of Medicine Division of Cardiology, Harbor-UCLA Medical.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010 FEDERICA.
Multislice CT Coronary Angiography
Electron Beam Tomography EBT. I’ve never heard of it, (and it doesn’t sound good) Electrons –Atomic particles –Have mass Wouldn’t a beam of particulate.
Screening for Coronary Artery Calcium with Computed Tomography: Angiography and Intervention in Patients with Scores Over 400 Screening for Coronary Artery.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Global impact of ischemic heart disease World Heart Federation, 2011.
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Mortality Incidence of Patients With Non-Obstructive Coronary Artery Disease Diagnosed by Computed Tomography Angiography Naser Ahmadi, MD, Vahid Nabavi,
HILLSBOROUGH COUNTY SHERIFF’S DEPARTMENT Saving Our Law Officers From Sudden Death and Heart Attacks.
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
Clinical Trial Results. org Long-Term Prognosis Associated with Coronary Calcification Matthew J. Budoff, MD, Leslee J. Shaw, PhD, Sandy T. Liu, Steven.
Monitoring CAC and IMT: A useful clinical tool? Cardiology Service Walter Reed Army Medical Center Walter Reed Army Health Care System NO CONFLICTS TO.
Laura Mucci, Pharm.D. Candidate Mercer University 2012 Preceptor: Dr. Rahimi February 2012.
Credentials, Reporting and Billing Matthew J. Budoff, MD, FACC Associate Professor of Medicine Division of Cardiology Harbor-UCLA Medical Center, Torrance.
Roles of Nuclear Cardiology, Cardiac Computed Tomography Cardiac Magnetic Resonance: Assessment of Patients with Suspected Coronary Artery Disease INT.
Ethnic Differences in the Prognostic Value of Coronary Artery Calcification for All-Cause Mortality Khurram Nasir MD MPH, Leslee J. Shaw PhD, Sandy T.
Published in Circulation 2003 Rory Hachamovitch, MD, MSc; Sean W. Hayes, MD; John D. Friedman, MD; Ishac Cohen PhD; Daniel S. Berman, MD Comparison of.
AA-2-1 Jerome D. Cohen, MD, FACC, FACP Professor of Internal Medicine / Cardiology Director, Preventive Cardiology Programs St. Louis University Health.
Predictive Value of Coronary Calcium Scoring Matthew Budoff, MD, FACC, FAHA Associate Professor of Medicine UCLA School of Medicine Director, Cardiac CT.
Coronary Artery Calcium
Ravi Doobay and Dr. Eric Harrison We care about the health of our firefighters Tampa Fire Rescue: Saving our Firefighters from Heart Disease.
The Century Health Trial A Comprehensive Integrated Strategy For Managing CAD K. Lance Gould, M.D. Martin Bucksbaum Distinguished University Chair, Professor.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2013 ACC/AHA Guideline on the Treatment of Blood.
CARDIAC CT IN SCREENING FOR CAD Hossein Nademi MD CARDIOLOGIST JAVADOL-A-EME HEART HOSPITAL OCT
Date of download: 5/30/2016 Copyright © The American College of Cardiology. All rights reserved. From: Coronary Computed Tomography Angiography as a Screening.
Multi-Slice CT for Coronary Calcium Scoring and Coronary Angiography John D. Symanski, M.D., F.A.C.C The Sanger Clinic, PA and Carolinas Medical Center.
TAHAR EL KANDOUSSI, SARA ECHERKI, NAWAL DOGHMI, MOHAMED CHERTI. SEcurite de l’Echocardiographie de stress : plutôt l’effort. Cardiology B Department, Ibn.
Are We There Yet ? Abdul H. Sankari, MD FACC FCCP.
Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease : The St Francis Heart Study Randomized Clinical Trial Temitope Foster,
Screening for CAD Nuclear Medicine prospective S.R.Zakavi,MD,IBNM Nuclear Medicine Research Center Mashhad University of Medical Sciences.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prognostic Value of Multislice Computed Tomography.
Matthew P. Ostrom, MD, Ambarish Gopal, MD, Naser Ahmadi, MD, Khurram Nasir, MD, MPH, Eric Yang, MD, Ioannis Kakadiaris, PHD, Ferdinand Flores, BS, Song.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate.
18th Annual Primary Care and Cardiovascular Symposium
US cost-effectiveness of simvastatin in 20,536 people at different levels of vascular disease risk: randomised placebo-controlled trial UK Medical Research.
CT for Evaluation & Treatment of Cardiovascular Disease
Wm. Guy Weigold, MD, FACC, FSCCT Director of Cardiac CT
Clinical need for determination of vulnerable plaques
The Role of Cardiac CT in Women
Phenotype vs. Genotype: Defining Severe Familial Hypercholesterolemia
Cholesterol practice questions
Neil J. Stone et al. JACC 2014;63:
Contemporary Evidence-Based Guidelines
LRC-CPPT and MRFIT Content Points:
CT coronary angiography and coronary calcium scoring
The following slides are from a Cardiology Scientific Update in which Dr. Gordon Moe reported and discussed an original presentation by Drs. Bjorn Dahlof,
HILLSBOROUGH COUNTY SHERIFF’S DEPARTMENT
Preventative Cardiology
The following slides highlight a report on a presentation at the American College of Cardiology 2004, Scientific Sessions, in New Orleans, Louisiana on.
Requested Information by CMS Team During April 30th Hearing
Presentation transcript:

Electron Beam Computed Tomography in the Age of 64 Slice CT Matthew J. Budoff, MD, FACC Associate Professor of Medicine Division of Cardiology Harbor-UCLA Medical Center, Torrance CA

5 USES OF Coronary Artery Calcium Use a calcium score to screen patients with moderate (intermediate) Framingham risk –Positive CAC scans indicate incremental risk –Alters therapeutic goal (LDL, BP, etc) Identify patients who do not need further cardiac evaluation (scores of zero) Consider serial imaging as ongoing management tool (progression) Improve compliance Non-invasive Angiography

Relative Risk DMSmokeHTN< >1000 EBT Coronary Calcium Score All Cause Mortality [NDR] n = 10,377 asymptomatic men and women f/u = yrs. Shaw, Raggi et al Radiology 2003 EBT found to be independent and incremental to risk factors All Cause Mortality in Patients Without Known CAD

Prediction of Cardiac Events in Asymptomatic Patients by EBT The St. Francis Heart Study, JACC 2005 SFHS 3 Baseline EBT Calcium Score Annual Event Rate (%) Calcium Score >100 vs <100 Relative Risk 9.5 Any Event 10.7 Cor. Event 9.9 MI/ SCD

Outcome Data – St Francis Randomized Trial This study was a double-blind, placebo-controlled randomized clinical trial of atorvastatin 20 mg daily, vitamin C 1 g daily, and vitamin E (alpha- tocopherol) 1,000 U daily, versus matching placebos in 1,005 asymptomatic, apparently healthy men and women age 50 to 70 years with coronary calcium scores at or above the 80th percentile for age and gender. All study participants also received aspirin 81 mg daily. Mean duration of treatment was 4.3 years. Treatment reduced low-density lipoprotein cholesterol by 39.1% to 43.4% (p < ), while reducing clinical endpoints by 30% (6.9% vs. 9.9%). Event rates were related to baseline calcium score (pre-specified analysis) and have been reduced in a subgroup of participants with baseline calcium score >400 (8.7% vs. 15.0%, p=0.046 [42% reduction]). The 30% reduction in the primary end point of this study is similar to the reduction of ASCVD events seen in other large randomized clinical trials of statins, a class of drugs with unquestionable efficacy in this application Arad Y et al. Treatment of Asymptomatic Adults with Elevated Coronary Calcium Scores with Atorvastatin, Vitamin C, and Vitamin E: The St. Francis Heart Study Randomized Clinical Trial. J Am Coll Cardiol 2005: 46:

Time to Follow-up (Years) Time to Follow-up (Years) Near- and Long-Term Survival from 2 Cohorts – over 35,000 patients n=10,377 n=25, % 97.8% 95.2% 90.4% 81.8% 99.4% 97.8% 94.5% 93.0% 76.9%  2 =1503, p<0.0001, interaction p<o.0001 CAC Score (5 Yr Mortality = 1.2%) (12-Yr Mortality = 2.1%)Difference % 99.4% 0.0% % 97.8% 0.0% % 94.5% 0.7% 401-1, % 93.0% 0.6% >1, % 76.9% 4.9%

Cooper Clinic Study - 10,782 Patients: 3.5 year follow-up Adjusted age, history of diabetes, hypertension, elevated cholesterol, over weight Ref Nonfatal MI & CHD Death 2.7 ( ) 6.0 (2.1-17) 9.7 (3.6-26) 21.1 (7.8-57)

Taylor et al – PACC Study – JACC patients, mean age 43 Coronary calcium was associated with an 11.8-fold increased risk for incident coronary heart disease (CHD) (p 0.002) in a Cox model controlling for the Framingham risk score. In young, asymptomatic men, the presence of coronary artery calcification provides substantial, cost-effective, independent prognostic value in predicting incident CHD that is incremental to measured coronary risk factors.

Anand EHJ 2006 – 510 Diabetics

MESA OUTCOMES CAC Score Number of hard 1 events/ Number at risk Hazard Ratio95% C.Ip-value Number of CHD events/ Number at risk Hazard Ratio95% C.Ip-value 08/ / / (2.37,11.73)< / (2.45,8.13)< / (4.79,24.27) < / (5.62,18.71)< or greater32/ (5.40,26.51)< / (7.91,25.22)< Includes only myocardial infarction and CHD death Detrano Et al. J Am Coll Cardiol 2007:49;101A.

MESA Study – 6,814 Patients: 3.5 year follow-up Fully adjusted – Detrano et al– ACC Abstract - JACC March 07 Ref Nonfatal MI & CHD Death 2.7 ( ) 6.0 (2.1-17) 9.7 (3.6-26) 21.1 (7.8-57)

Calcium Versus Framingham n = 5 n = 27 n = 18 n = 4 n = 29 n = 17 n = 1 n = 5 n = 44 Myocardial Infarction (%)

“measurement of coronary calcium is an option for advanced risk assessment. High coronary calcium scores (e.g., >75 th percentile for age and sex) denotes advanced atherosclerosis and provides rationale for intensified LDL-lowering therapy.” NCEP ATP-III : Noninvasive Testing

European Guidelines European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (2003) which state that “Coronary calcium scanning is thus especially suited for patients at medium risk”, and use CAC to qualify conventional risk analysis.

AHA – Circulation 2005 This recommendation to measure atherosclerosis burden, in clinically selected intermediate–CAD risk patients (eg, those with a 10% to 20% Framingham 10-year risk estimate) to refine clinical risk prediction and to select patients for altered targets for lipid-lowering therapies.

MEDICARE LCD- California 10. Quantitative evaluation of coronary calcium to be used as a triage tool in patients with chest pain of suspected cardiac etiology or clear evidence of myocardial ischemia and unknown Agatston score to determine the appropriateness of coronary CTA vs. catheter coronary angiography. 11. Quantitative evaluation of coronary calcium to be used as a triage tool for lipid-lowering therapy in patients with an intermediate to high Framingham risk score. Per recommendations of the American College of Cardiology, California chapter, and California Radiological Society, two of the following diagnoses should be present: diabetes, metabolic syndrome, hypertension, family history of cardiac or vascular disease, lipid abnormalities, smoking, or obesity. Since patients are generally over age 65, this is a total of 3 Framingham risk factors. 12. Quantitative evaluation of coronary calcium in patients with an equivocal stress imaging test or in cases in which discordance exists between stress imaging testing and clinical findings.

Blue Shield – February 2005

New Guidelines From AHA

AHA 2006 virtually all of the prognostic and epidemiological data derived for CACP have been performed with EBCT On the basis of the substantial validation data, EBCT remains the reference standard for CACP measurement The AHA Writing Group proposes that the following minimum requirements be met in scanning for CAC: 1. Use of an electron beam scanner or a 4-level (or greater) MDCT scanner

AHA – CT Angiography Where MDCT is used for CT angiography, the AHA Writing Group currently recommends a minimum of 16-slice capability, submillimeter collimation, and 0.42-second gantry rotation with retrospective ECG gating. If EBCT is used, 1.5-mm slice thickness should be used.

Radiology 2005; 235:723–727

Cardiac CT Equipment Recommendations The availability of a multi–detector row helical CT or an electron-beam CT scanner is a requirement for cardiac CT applications, especially for coronary artery calcium scoring and CT angiography. For multi–detector row CT, at least four detector rows are preferred for calcium scoring and at least 16 are preferred for CT coronary angiography.

Presenter Disclosure Information Disclosure Information... The following relationships exist related to this presentation: Budoff MJ – speakers Bureau, GE

Limitations of Coronary Angiography 15-35% of all angiograms done have no significant luminal narrowing Luminogram – no wall (plaque) information Average costs high, reimbursement to physician - limited

Coronary artery imaging: - small diameters (~1-4 mm) - complex anatomy - rapid motion

Electron Beam Tomography (EBT) Robust and proven CT coronary imaging Low Radiation ( mSev) e-Speed: 1.5 mm slice thickness 50 ms temporal resolution Limitations: 2 images per heart beat Heart Rates < 120 bpm High Calcium Scores/Stents

Electron Beam Tomography (EBT) 50 ms image acquisition time 1.5 mm slice thickness

Electron Beam CT CORONARY ANGIOGRAPHY 20 MINUTE PROCEDURE Intravenous access required REQUIRES ml CONTRAST (antecubital) Iodinated Dye (same as cath lab) Breath-hold seconds per study Images available within minutes, interpretation time 15 minutes/study

Non-invasive Angiography (EBA) Rasouli, AHA % 92% 94%

Methodology for improved detection of coronary stenoses with computed tomographic angiography – AHJ patients evaluated with cath EBA correctly classified 49 of 53 patients (92%) as having at least 1 coronary stenosis. Overall, 103 stenoses with 50% diameter reduction were present, and 93 of these lesions were correctly detected by EBA (sensitivity 90%, specificity 93%, positive predictive value 84%, and negative predictive value 96%). Only 5% of vessels could not be assessed, predominantly due to significant calcification.

EBA vs. MIBI Cardiac CT Angiography (CTA) and Nuclear Myocardial Perfusion Imaging (MPI)—A Comparison in Detecting Significant Coronary Artery Disease1 Matthew J. Budoff, MD, - Acad Rad

EBA vs. MIBI EBA demonstrated significant higher sensitivity than MPI (95% vs. 81%, P.05). EBA demonstrated significantly higher specificity than both MPI (89% versus 78%, P.04) and CAC (56%, P.002). EBA also performed better in a per-vessel analysis (sensitivity 94%, specificity 96%) than both nuclear and CAC

EBT – C150 Normal dominant Right coronary artery 80% stenosis of distal LAD, after large diagonal

EBT E-speed Normal distal RCA AND PDA

Electron Beam Angiogram

Circumflex and OM

EBCT ANGIOGRAM DURING A-FIB

MSCT 16 slice SOFT PLAQUE WITH EBCT

Detection of SOFT Plaque with EBT or MDCT Potential role in risk assessment? - Accuracy / Quantification – underestimates plaque significantly (Achenbach Circ, 04) - Reproducibility? - Progression over time? - Prognostic value? - Additive Data to Calcium or level of obstruction?

Valves/Wall Motion

Coronary Veins - Pre-BiV Pacer

Pulmonary Veins

Carotids

Renal Angiograms

ALARA PRINCIPAL - Radiation EBT angiography mSv MSCT angiography mSv Cath mSv *Dose Modulation – MSCT 5-8 mSv* Morin et al, Circulation 2003

When To Use EBA even with 64 available? High heart rates Younger patients (<40?, definitely <30 years old) All pediatric applications CHF – heart rates Afib patients

Diagnostic tool with high negative predictive value (~98%) if image quality is sufficient But accuracy is < 100% and not all vessels are visualized CONCLUSIONS